Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[The hematology clinic].

W Feremans1, A Kentos, V Robin

  • 1wfereman@ulb.ac.be

Revue Medicale De Bruxelles
|February 15, 2003
PubMed
Summary
This summary is machine-generated.

This hematology clinic performs 30 stem cell transplants annually, focusing on multidrug resistance and advanced leukemia treatments. Research advances include monoclonal antibodies and purine analog administration for improved patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Septicaemia And Endocarditis Due to Streptococci of Lancefield Group.

Acta clinica Belgica·2016
Same author

Myelofibrosis patients in Belgium: disease characteristics.

Acta clinica Belgica·2014
Same author

[Cardiac arrhythmias and superior vena cava syndrome revealing a Richter's syndrome].

Revue medicale de Bruxelles·2014
Same author

Lenalidomide in relapsed refractory myeloma patients: impact of previous response to bortezomib and thalidomide on treatment efficacy. Results of a medical need program in Belgium.

Acta clinica Belgica·2011
Same author

[Non Hodgkin's lymphomas: a major breakthrough with immunotherapy].

Revue medicale de Bruxelles·2011
Same author

The Belgian 2010 consensus recommendations for the treatment of multiple myeloma.

Acta clinica Belgica·2010

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Context:

  • Established in 1993, the clinic conducts approximately 30 blood stem cell transplantations yearly.
  • Manages over 8,000 hospital days and 2,300 consultations annually.
  • Actively participates in international research groups like EORTC Leukaemia Group and EBMT.

Purpose:

  • To advance the management of hematologic malignancies and lymphoproliferative diseases.
  • To investigate multidrug resistance (MDR) mechanisms in blood cancers.
  • To explore novel therapeutic strategies, including monoclonal antibodies and purine analogs.

Summary:

  • The clinic specializes in peripheral blood stem cell transplantation and the study of multidrug resistance (MDR) in hematologic malignancies.
  • Research contributions include monoclonal antibody treatment for lymphoproliferative diseases and autotransplant purification in multiple myeloma.

Related Experiment Videos

  • Investigated new administration methods for purine analogs in chronic lymphocytic leukemia.

    • Impact:

    • Significant contributions to the understanding and treatment of hematologic malignancies.
    • Improved management protocols for stem cell transplantation and leukemia.
    • Development of targeted therapies for blood cancers, enhancing patient care and outcomes.